{"transactions":[{"id":891839,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2026-02-20T17:28:08.000Z","date":"2026-02-20","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2027, subject to the reporting person continuing to provide service to the Issuer through each such vesting date."}],"balance_after":45000,"derivative":{"exercise_price":1.8,"expiration_date":"2036-02-19","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001683811-26-000002","document":"wk-form4_1771626484.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000168381126000002/wk-form4_1771626484.xml","form_type":"4"}},{"id":1254302,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2025-02-21T20:16:25.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":40500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2026, subject to the reporting person continuing to provide service to the Issuer\nthrough each such vesting date."}],"balance_after":40500,"derivative":{"exercise_price":1.41,"expiration_date":"2035-02-19","underlying":"Common Stock","underlying_shares":40500},"source":{"system":"sec-edgar","filing":"0001683811-25-000003","document":"wk-form4_1740186979.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000168381125000003/wk-form4_1740186979.xml","form_type":"4"}},{"id":1627045,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2024-02-22T17:08:41.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":39500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2025, subject to the reporting person continuing to provide service to the Issuer through each such vesting date."}],"balance_after":39500,"derivative":{"exercise_price":6.81,"expiration_date":"2034-02-19","underlying":"Common Stock","underlying_shares":39500},"source":{"system":"sec-edgar","filing":"0001628280-24-006412","document":"wk-form4_1708639705.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000162828024006412/wk-form4_1708639705.xml","form_type":"4"}},{"id":1997514,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2023-02-23T17:12:03.000Z","date":"2023-02-21","kind":"grant","acquired":true,"shares":21500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 21, 2024,  subject to the reporting person continuing to provide service to the Issuer through each such vesting date."}],"balance_after":21500,"derivative":{"exercise_price":6.12,"expiration_date":"2033-02-20","underlying":"Common Stock","underlying_shares":21500},"source":{"system":"sec-edgar","filing":"0001619856-23-000024","document":"wf-form4_167719030244436.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000161985623000024/wf-form4_167719030244436.xml","form_type":"4"}},{"id":2077211,"issuer":{"id":4458,"kind":"organization","name":"Zymeworks Inc.","symbol":"ZYME"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-23T19:00:37.000Z","date":"2022-12-21","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest on date of next annual general meeting following grant date of December 21, 2022."}],"balance_after":25000,"derivative":{"exercise_price":8.75,"expiration_date":"2032-12-20","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-22-039327","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000089924322039327/doc4.xml","form_type":"4"}},{"id":2420160,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-02-01T16:07:22.000Z","date":"2022-01-28","kind":"grant","acquired":true,"shares":155000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the total stock option will vest and become exercisable monthly on the same day of each month following the vesting commencement date of January 28, 2022, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":155000,"derivative":{"exercise_price":5.03,"expiration_date":"2032-01-27","underlying":"Common Stock","underlying_shares":155000},"source":{"system":"sec-edgar","filing":"0001209191-22-005890","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919122005890/doc4.xml","form_type":"4"}},{"id":2463251,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2021-12-21T17:38:12.000Z","date":"2021-12-20","kind":"grant","acquired":true,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on December 20, 2022, subject to the reporting person continuing to provide service to the Issuer through each such vesting date."}],"balance_after":27500,"derivative":{"exercise_price":15.16,"expiration_date":"2031-12-19","underlying":"Common Stock","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0001209191-21-070823","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919121070823/doc4.xml","form_type":"4"}},{"id":2513865,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-11-15T16:03:19.000Z","date":"2021-11-11","kind":"grant","acquired":true,"shares":155000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fifty percent of the stock option shall be fully vested and exercisable on the first anniversary of the vesting commencement date, November 11, 2022, and thereafter twenty-five percent of the stock option shall vest on each May 11, 2023, and November 11, 2023."}],"balance_after":155000,"derivative":{"exercise_price":7.73,"expiration_date":"2031-11-11","underlying":"Common Stock","underlying_shares":155000},"source":{"system":"sec-edgar","filing":"0001209191-21-064441","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919121064441/doc4.xml","form_type":"4"}},{"id":2724205,"issuer":{"id":12038,"kind":"organization","name":"Zymeworks BC Inc.","symbol":"ZYME"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-07T20:45:24.000Z","date":"2021-05-06","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest on date of next annual general meeting following grant date of May 6, 2021."}],"balance_after":9000,"derivative":{"exercise_price":29.49,"expiration_date":"2031-05-05","underlying":"Common Shares","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0000899243-21-018765","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000089924321018765/doc4.xml","form_type":"4"}},{"id":2891350,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-01-29T20:00:28.000Z","date":"2021-01-28","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 1/48th of the shares subject to the option on February 28, 2021, and thereafter vests as to 1/48th of the shares in equal monthly installments at the end of each month, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":80000,"derivative":{"exercise_price":18.66,"expiration_date":"2031-01-27","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001209191-21-006313","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919121006313/doc4.xml","form_type":"4"}},{"id":3141728,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-05-20T18:34:30.000Z","date":"2020-05-18","kind":"exercise","acquired":false,"shares":1522,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested and became exercisable as to 25% of the shares subject to the option on November 16, 2019, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":45625,"derivative":{"exercise_price":2.12,"expiration_date":"2028-11-16","underlying":"Common Stock","underlying_shares":1522},"source":{"system":"sec-edgar","filing":"0001209191-20-031019","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120031019/doc4.xml","form_type":"4"}},{"id":3141727,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-05-20T18:34:30.000Z","date":"2020-05-18","kind":"sale","acquired":false,"shares":1522,"price":14.7691,"value":22478.5702,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $14.70 to $14.90 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":45754,"source":{"system":"sec-edgar","filing":"0001209191-20-031019","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120031019/doc4.xml","form_type":"4"}},{"id":3141726,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-05-20T18:34:30.000Z","date":"2020-05-18","kind":"exercise","acquired":true,"shares":1522,"price":2.12,"value":3226.64,"ownership":{"direct":true},"balance_after":47276,"source":{"system":"sec-edgar","filing":"0001209191-20-031019","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120031019/doc4.xml","form_type":"4"}},{"id":3153556,"issuer":{"id":12038,"kind":"organization","name":"Zymeworks BC Inc.","symbol":"ZYME"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-12T06:32:53.000Z","date":"2020-05-08","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest on date of next annual general meeting following grant date of May 8, 2020."}],"balance_after":9000,"derivative":{"exercise_price":35.49,"expiration_date":"2030-05-07","underlying":"Common Shares","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0000899243-20-012778","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000089924320012778/doc4.xml","form_type":"4"}},{"id":3162395,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-05-05T16:35:04.000Z","date":"2020-05-01","kind":"exercise","acquired":false,"shares":5826,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested and became exercisable as to 25% of the shares subject to the option on October 1, 2019, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":168926,"derivative":{"exercise_price":2.12,"expiration_date":"2028-10-17","underlying":"Common Stock","underlying_shares":5826},"source":{"system":"sec-edgar","filing":"0001209191-20-027143","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120027143/doc4.xml","form_type":"4"}},{"id":3162394,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-05-05T16:35:04.000Z","date":"2020-05-01","kind":"sale","acquired":false,"shares":5826,"price":12.0668,"value":70301.1768,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $11.81 to $12.31 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":45754,"source":{"system":"sec-edgar","filing":"0001209191-20-027143","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120027143/doc4.xml","form_type":"4"}},{"id":3162393,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-05-05T16:35:04.000Z","date":"2020-05-01","kind":"exercise","acquired":true,"shares":5826,"price":2.12,"value":12351.12,"ownership":{"direct":true},"balance_after":51580,"source":{"system":"sec-edgar","filing":"0001209191-20-027143","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120027143/doc4.xml","form_type":"4"}},{"id":3174797,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-04-17T19:10:43.000Z","date":"2020-04-17","kind":"exercise","acquired":false,"shares":1021,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested and became exercisable as to 25% of the shares subject to the option on November 16, 2019, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":47147,"derivative":{"exercise_price":2.12,"expiration_date":"2028-11-16","underlying":"Common Stock","underlying_shares":1021},"source":{"system":"sec-edgar","filing":"0001209191-20-024947","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120024947/doc4.xml","form_type":"4"}},{"id":3174796,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-04-17T19:10:43.000Z","date":"2020-04-16","kind":"exercise","acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested and became exercisable as to 25% of the shares subject to the option on November 16, 2019, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":48168,"derivative":{"exercise_price":2.12,"expiration_date":"2028-11-16","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001209191-20-024947","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120024947/doc4.xml","form_type":"4"}},{"id":3174795,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-04-17T19:10:43.000Z","date":"2020-04-17","kind":"sale","acquired":false,"shares":1021,"price":12.0765,"value":12330.1065,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $12.00 to $12.15 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":45754,"source":{"system":"sec-edgar","filing":"0001209191-20-024947","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120024947/doc4.xml","form_type":"4"}},{"id":3174794,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-04-17T19:10:43.000Z","date":"2020-04-17","kind":"exercise","acquired":true,"shares":1021,"price":2.12,"value":2164.52,"ownership":{"direct":true},"balance_after":46775,"source":{"system":"sec-edgar","filing":"0001209191-20-024947","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120024947/doc4.xml","form_type":"4"}},{"id":3174793,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-04-17T19:10:43.000Z","date":"2020-04-16","kind":"sale","acquired":false,"shares":500,"price":12,"value":6000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":45754,"source":{"system":"sec-edgar","filing":"0001209191-20-024947","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120024947/doc4.xml","form_type":"4"}},{"id":3174792,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-04-17T19:10:43.000Z","date":"2020-04-16","kind":"exercise","acquired":true,"shares":500,"price":2.12,"value":1060.0,"ownership":{"direct":true},"balance_after":46254,"source":{"system":"sec-edgar","filing":"0001209191-20-024947","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120024947/doc4.xml","form_type":"4"}},{"id":3176878,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-04-15T16:48:43.000Z","date":"2020-04-13","kind":"exercise","acquired":false,"shares":4556,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested and became exercisable as to 25% of the shares subject to the option on October 1, 2019, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":174752,"derivative":{"exercise_price":2.12,"expiration_date":"2028-10-17","underlying":"Common Stock","underlying_shares":4556},"source":{"system":"sec-edgar","filing":"0001209191-20-024489","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120024489/doc4.xml","form_type":"4"}},{"id":3176877,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-04-15T16:48:43.000Z","date":"2020-04-13","kind":"sale","acquired":false,"shares":4556,"price":12.063,"value":54959.028,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $12.00 to $12.21 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":45754,"source":{"system":"sec-edgar","filing":"0001209191-20-024489","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120024489/doc4.xml","form_type":"4"}},{"id":3176876,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-04-15T16:48:43.000Z","date":"2020-04-13","kind":"exercise","acquired":true,"shares":4556,"price":2.12,"value":9658.72,"ownership":{"direct":true},"balance_after":50310,"source":{"system":"sec-edgar","filing":"0001209191-20-024489","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120024489/doc4.xml","form_type":"4"}},{"id":3180045,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-04-08T18:10:11.000Z","date":"2020-04-07","kind":"exercise","acquired":false,"shares":570,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested and became exercisable as to 25% of the shares subject to the option on October 1, 2019, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":179308,"derivative":{"exercise_price":2.12,"expiration_date":"2028-10-17","underlying":"Common Stock","underlying_shares":570},"source":{"system":"sec-edgar","filing":"0001209191-20-023954","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120023954/doc4.xml","form_type":"4"}},{"id":3180044,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-04-08T18:10:11.000Z","date":"2020-04-06","kind":"exercise","acquired":false,"shares":700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested and became exercisable as to 25% of the shares subject to the option on October 1, 2019, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":179878,"derivative":{"exercise_price":2.12,"expiration_date":"2028-10-17","underlying":"Common Stock","underlying_shares":700},"source":{"system":"sec-edgar","filing":"0001209191-20-023954","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120023954/doc4.xml","form_type":"4"}},{"id":3180043,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-04-08T18:10:11.000Z","date":"2020-04-07","kind":"sale","acquired":false,"shares":570,"price":12,"value":6840.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":45754,"source":{"system":"sec-edgar","filing":"0001209191-20-023954","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120023954/doc4.xml","form_type":"4"}},{"id":3180042,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-04-08T18:10:11.000Z","date":"2020-04-07","kind":"exercise","acquired":true,"shares":570,"price":2.12,"value":1208.4,"ownership":{"direct":true},"balance_after":46324,"source":{"system":"sec-edgar","filing":"0001209191-20-023954","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120023954/doc4.xml","form_type":"4"}},{"id":3180041,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-04-08T18:10:11.000Z","date":"2020-04-06","kind":"sale","acquired":false,"shares":700,"price":12.0014,"value":8400.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $12.00 to $12.01 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":45754,"source":{"system":"sec-edgar","filing":"0001209191-20-023954","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120023954/doc4.xml","form_type":"4"}},{"id":3180040,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-04-08T18:10:11.000Z","date":"2020-04-06","kind":"exercise","acquired":true,"shares":700,"price":2.12,"value":1484.0,"ownership":{"direct":true},"balance_after":46454,"source":{"system":"sec-edgar","filing":"0001209191-20-023954","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120023954/doc4.xml","form_type":"4"}},{"id":3203712,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-03-18T17:28:17.000Z","date":"2020-03-17","kind":"exercise","acquired":false,"shares":1520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vested and became exercisable as to 25% of the shares subject to the option on November 16, 2019, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":48668,"derivative":{"exercise_price":2.12,"expiration_date":"2028-11-16","underlying":"Common Stock","underlying_shares":1520},"source":{"system":"sec-edgar","filing":"0001209191-20-020052","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120020052/doc4.xml","form_type":"4"}},{"id":3203711,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-03-18T17:28:17.000Z","date":"2020-03-16","kind":"exercise","acquired":false,"shares":1,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vested and became exercisable as to 25% of the shares subject to the option on November 16, 2019, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":50188,"derivative":{"exercise_price":2.12,"expiration_date":"2028-11-16","underlying":"Common Stock","underlying_shares":1},"source":{"system":"sec-edgar","filing":"0001209191-20-020052","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120020052/doc4.xml","form_type":"4"}},{"id":3203710,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-03-18T17:28:17.000Z","date":"2020-03-17","kind":"sale","acquired":false,"shares":1520,"price":12,"value":18240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":45754,"source":{"system":"sec-edgar","filing":"0001209191-20-020052","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120020052/doc4.xml","form_type":"4"}},{"id":3203709,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-03-18T17:28:17.000Z","date":"2020-03-17","kind":"exercise","acquired":true,"shares":1520,"price":2.12,"value":3222.4,"ownership":{"direct":true},"balance_after":47274,"source":{"system":"sec-edgar","filing":"0001209191-20-020052","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120020052/doc4.xml","form_type":"4"}},{"id":3203708,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-03-18T17:28:17.000Z","date":"2020-03-16","kind":"sale","acquired":false,"shares":1,"price":12,"value":12.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":45754,"source":{"system":"sec-edgar","filing":"0001209191-20-020052","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120020052/doc4.xml","form_type":"4"}},{"id":3203707,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-03-18T17:28:17.000Z","date":"2020-03-16","kind":"exercise","acquired":true,"shares":1,"price":2.12,"value":2.12,"ownership":{"direct":true},"balance_after":45755,"source":{"system":"sec-edgar","filing":"0001209191-20-020052","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120020052/doc4.xml","form_type":"4"}},{"id":3235606,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-03-03T21:31:57.000Z","date":"2020-03-02","kind":"exercise","acquired":false,"shares":5826,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested and became exercisable as to 25% of the shares subject to the option on October 1, 2019, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":180578,"derivative":{"exercise_price":2.12,"expiration_date":"2028-10-17","underlying":"Common Stock","underlying_shares":5826},"source":{"system":"sec-edgar","filing":"0001209191-20-015855","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120015855/doc4.xml","form_type":"4"}},{"id":3235605,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-03-03T21:31:57.000Z","date":"2020-03-02","kind":"sale","acquired":false,"shares":5826,"price":14.68,"value":85525.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $14.55 to $15.37 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":45754,"source":{"system":"sec-edgar","filing":"0001209191-20-015855","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120015855/doc4.xml","form_type":"4"}},{"id":3235604,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-03-03T21:31:57.000Z","date":"2020-03-02","kind":"exercise","acquired":true,"shares":5826,"price":2.12,"value":12351.12,"ownership":{"direct":true},"balance_after":51580,"source":{"system":"sec-edgar","filing":"0001209191-20-015855","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120015855/doc4.xml","form_type":"4"}},{"id":3261124,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-02-20T17:11:35.000Z","date":"2020-02-18","kind":"exercise","acquired":false,"shares":1521,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vested and became exercisable as to 25% of the shares subject to the option on November 16, 2019, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":50189,"derivative":{"exercise_price":2.12,"expiration_date":"2028-11-16","underlying":"Common Stock","underlying_shares":1521},"source":{"system":"sec-edgar","filing":"0001209191-20-011190","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120011190/doc4.xml","form_type":"4"}},{"id":3261123,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-02-20T17:11:35.000Z","date":"2020-02-18","kind":"sale","acquired":false,"shares":1521,"price":15,"value":22815.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":45754,"source":{"system":"sec-edgar","filing":"0001209191-20-011190","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120011190/doc4.xml","form_type":"4"}},{"id":3261122,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-02-20T17:11:35.000Z","date":"2020-02-18","kind":"exercise","acquired":true,"shares":1521,"price":2.12,"value":3224.52,"ownership":{"direct":true},"balance_after":47275,"source":{"system":"sec-edgar","filing":"0001209191-20-011190","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120011190/doc4.xml","form_type":"4"}},{"id":3293551,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-02-04T20:11:58.000Z","date":"2020-02-03","kind":"exercise","acquired":false,"shares":5826,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vested and became exercisable as to 25% of the shares subject to the option on October 1, 2019, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":186404,"derivative":{"exercise_price":2.12,"expiration_date":"2028-10-17","underlying":"Common Stock","underlying_shares":5826},"source":{"system":"sec-edgar","filing":"0001209191-20-006706","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120006706/doc4.xml","form_type":"4"}},{"id":3293550,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-02-04T20:11:58.000Z","date":"2020-01-31","kind":"grant","acquired":true,"shares":75440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests and becomes exercisable as to 1/48th of the shares subject to the option on February 29, 2020, and thereafter vests as to 1/48th of the shares in equal monthly installments at the end of each month, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":75440,"derivative":{"exercise_price":13.29,"expiration_date":"2030-01-30","underlying":"Common Stock","underlying_shares":75440},"source":{"system":"sec-edgar","filing":"0001209191-20-006706","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120006706/doc4.xml","form_type":"4"}},{"id":3293549,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-02-04T20:11:58.000Z","date":"2020-02-03","kind":"sale","acquired":false,"shares":5826,"price":13.9043,"value":81006.4518,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $13.72 to $14.27 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":45754,"source":{"system":"sec-edgar","filing":"0001209191-20-006706","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120006706/doc4.xml","form_type":"4"}},{"id":3293548,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-02-04T20:11:58.000Z","date":"2020-02-03","kind":"exercise","acquired":true,"shares":5826,"price":2.12,"value":12351.12,"ownership":{"direct":true},"balance_after":51580,"source":{"system":"sec-edgar","filing":"0001209191-20-006706","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120006706/doc4.xml","form_type":"4"}},{"id":3306953,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-01-21T20:05:05.000Z","date":"2020-01-16","kind":"exercise","acquired":false,"shares":1521,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested and became exercisable as to 25% of the shares subject to the option on November 16, 2019, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":51710,"derivative":{"exercise_price":2.12,"expiration_date":"2028-11-16","underlying":"Common Stock","underlying_shares":1521},"source":{"system":"sec-edgar","filing":"0001209191-20-004374","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120004374/doc4.xml","form_type":"4"}},{"id":3306952,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-01-21T20:05:05.000Z","date":"2020-01-16","kind":"sale","acquired":false,"shares":1521,"price":14.9408,"value":22724.9568,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $14.90 to $15.00 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":45754,"source":{"system":"sec-edgar","filing":"0001209191-20-004374","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120004374/doc4.xml","form_type":"4"}},{"id":3306951,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-01-21T20:05:05.000Z","date":"2020-01-16","kind":"exercise","acquired":true,"shares":1521,"price":2.12,"value":3224.52,"ownership":{"direct":true},"balance_after":47275,"source":{"system":"sec-edgar","filing":"0001209191-20-004374","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120004374/doc4.xml","form_type":"4"}},{"id":3320310,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-01-06T21:46:43.000Z","date":"2020-01-02","kind":"exercise","acquired":false,"shares":5826,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested and became exercisable as to 25% of the shares subject to the option on October 1, 2019, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":192230,"derivative":{"exercise_price":2.12,"expiration_date":"2028-10-17","underlying":"Common Stock","underlying_shares":5826},"source":{"system":"sec-edgar","filing":"0001209191-20-002179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120002179/doc4.xml","form_type":"4"}},{"id":3320309,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-01-06T21:46:43.000Z","date":"2020-01-02","kind":"sale","acquired":false,"shares":5826,"price":14.1779,"value":82600.4454,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $14.0455 to $14.55 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":45754,"source":{"system":"sec-edgar","filing":"0001209191-20-002179","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120002179/doc4.xml","form_type":"4"}},{"id":3320308,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-01-06T21:46:43.000Z","date":"2020-01-02","kind":"exercise","acquired":true,"shares":5826,"price":2.12,"value":12351.12,"ownership":{"direct":true},"balance_after":51580,"source":{"system":"sec-edgar","filing":"0001209191-20-002179","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919120002179/doc4.xml","form_type":"4"}},{"id":3337757,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-12-18T16:14:30.000Z","date":"2019-12-16","kind":"exercise","acquired":false,"shares":1521,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested and became exercisable as to 25% of the shares subject to the option on November 16, 2019, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":53231,"derivative":{"exercise_price":2.12,"expiration_date":"2028-11-16","underlying":"Common Stock","underlying_shares":1521},"source":{"system":"sec-edgar","filing":"0001209191-19-061097","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919119061097/doc4.xml","form_type":"4"}},{"id":3337756,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-12-18T16:14:30.000Z","date":"2019-12-16","kind":"sale","acquired":false,"shares":1521,"price":17.0201,"value":25887.5721,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $17.01 to $17.35 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":45754,"source":{"system":"sec-edgar","filing":"0001209191-19-061097","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919119061097/doc4.xml","form_type":"4"}},{"id":3337755,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-12-18T16:14:30.000Z","date":"2019-12-16","kind":"exercise","acquired":true,"shares":1521,"price":2.12,"value":3224.52,"ownership":{"direct":true},"balance_after":47275,"source":{"system":"sec-edgar","filing":"0001209191-19-061097","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919119061097/doc4.xml","form_type":"4"}},{"id":3353253,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-12-04T16:42:13.000Z","date":"2019-12-02","kind":"exercise","acquired":false,"shares":5826,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vested and became exercisable as to 25% of the shares subject to the option on October 1, 2019, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":198056,"derivative":{"exercise_price":2.12,"expiration_date":"2028-10-17","underlying":"Common Stock","underlying_shares":5826},"source":{"system":"sec-edgar","filing":"0001209191-19-059085","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919119059085/doc4.xml","form_type":"4"}},{"id":3353252,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-12-04T16:42:13.000Z","date":"2019-12-02","kind":"sale","acquired":false,"shares":5826,"price":17.98,"value":104751.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":45754,"source":{"system":"sec-edgar","filing":"0001209191-19-059085","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919119059085/doc4.xml","form_type":"4"}},{"id":3353251,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-12-04T16:42:13.000Z","date":"2019-12-02","kind":"exercise","acquired":true,"shares":5826,"price":2.12,"value":12351.12,"ownership":{"direct":true},"balance_after":51580,"source":{"system":"sec-edgar","filing":"0001209191-19-059085","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919119059085/doc4.xml","form_type":"4"}},{"id":3367266,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-11-19T16:24:26.000Z","date":"2019-11-18","kind":"exercise","acquired":false,"shares":18252,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested and became exercisable as to 25% of the shares subject to the option on November 16, 2019, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":54752,"derivative":{"exercise_price":2.12,"expiration_date":"2028-11-16","underlying":"Common Stock","underlying_shares":18252},"source":{"system":"sec-edgar","filing":"0001209191-19-057167","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919119057167/doc4.xml","form_type":"4"}},{"id":3367265,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-19T16:24:26.000Z","date":"2019-11-18","kind":"sale","acquired":false,"shares":1000,"price":14,"value":14000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":45754,"source":{"system":"sec-edgar","filing":"0001209191-19-057167","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919119057167/doc4.xml","form_type":"4"}},{"id":3367264,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-19T16:24:26.000Z","date":"2019-11-18","kind":"sale","acquired":false,"shares":17252,"price":13.3297,"value":229963.9844,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $13.00 to $13.95 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":46754,"source":{"system":"sec-edgar","filing":"0001209191-19-057167","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919119057167/doc4.xml","form_type":"4"}},{"id":3367263,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-19T16:24:26.000Z","date":"2019-11-18","kind":"exercise","acquired":true,"shares":18252,"price":2.12,"value":38694.24,"ownership":{"direct":true},"balance_after":64006,"source":{"system":"sec-edgar","filing":"0001209191-19-057167","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919119057167/doc4.xml","form_type":"4"}},{"id":3381141,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-11-05T16:09:31.000Z","date":"2019-11-01","kind":"exercise","acquired":false,"shares":5826,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested and became exercisable as to 25% of the shares subject to the option on October 1, 2019, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":203882,"derivative":{"exercise_price":2.12,"expiration_date":"2028-10-17","underlying":"Common Stock","underlying_shares":5826},"source":{"system":"sec-edgar","filing":"0001209191-19-055169","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919119055169/doc4.xml","form_type":"4"}},{"id":3381140,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-05T16:09:31.000Z","date":"2019-11-01","kind":"sale","acquired":false,"shares":5826,"price":13.1654,"value":76701.6204,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $13.00 to $13.3822 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":45754,"source":{"system":"sec-edgar","filing":"0001209191-19-055169","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919119055169/doc4.xml","form_type":"4"}},{"id":3381139,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-05T16:09:31.000Z","date":"2019-11-01","kind":"exercise","acquired":true,"shares":5826,"price":2.12,"value":12351.12,"ownership":{"direct":true},"balance_after":51580,"source":{"system":"sec-edgar","filing":"0001209191-19-055169","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919119055169/doc4.xml","form_type":"4"}},{"id":3393266,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-10-16T17:14:36.000Z","date":"2019-10-15","kind":"exercise","acquired":false,"shares":11698,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vested and became exercisable as to 25% of the shares subject to the option on October 1, 2019, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":209708,"derivative":{"exercise_price":2.12,"expiration_date":"2028-10-17","underlying":"Common Stock","underlying_shares":11698},"source":{"system":"sec-edgar","filing":"0001209191-19-053306","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919119053306/doc4.xml","form_type":"4"}},{"id":3393265,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-10-16T17:14:36.000Z","date":"2019-10-14","kind":"exercise","acquired":false,"shares":12452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vested and became exercisable as to 25% of the shares subject to the option on October 1, 2019, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":221406,"derivative":{"exercise_price":2.12,"expiration_date":"2028-10-17","underlying":"Common Stock","underlying_shares":12452},"source":{"system":"sec-edgar","filing":"0001209191-19-053306","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919119053306/doc4.xml","form_type":"4"}},{"id":3393264,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-10-16T17:14:36.000Z","date":"2019-10-15","kind":"sale","acquired":false,"shares":11698,"price":13.2058,"value":154481.4484,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $13.01 to $13.39 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":45754,"source":{"system":"sec-edgar","filing":"0001209191-19-053306","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919119053306/doc4.xml","form_type":"4"}},{"id":3393263,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-10-16T17:14:36.000Z","date":"2019-10-15","kind":"exercise","acquired":true,"shares":11698,"price":2.12,"value":24799.76,"ownership":{"direct":true},"balance_after":57452,"source":{"system":"sec-edgar","filing":"0001209191-19-053306","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919119053306/doc4.xml","form_type":"4"}},{"id":3393262,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-10-16T17:14:36.000Z","date":"2019-10-14","kind":"sale","acquired":false,"shares":12452,"price":13.2734,"value":165280.3768,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $13.00 to $13.77 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":45754,"source":{"system":"sec-edgar","filing":"0001209191-19-053306","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919119053306/doc4.xml","form_type":"4"}},{"id":3393261,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-10-16T17:14:36.000Z","date":"2019-10-14","kind":"exercise","acquired":true,"shares":12452,"price":2.12,"value":26398.24,"ownership":{"direct":true},"balance_after":58206,"source":{"system":"sec-edgar","filing":"0001209191-19-053306","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919119053306/doc4.xml","form_type":"4"}},{"id":3535864,"issuer":{"id":12038,"kind":"organization","name":"Zymeworks BC Inc.","symbol":"ZYME"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-08T16:26:05.000Z","date":"2019-05-06","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest on date of next annual general meeting following grant date of May 6, 2019."}],"balance_after":10000,"derivative":{"exercise_price":19.11,"expiration_date":"2029-05-05","underlying":"Common Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-19-012639","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000089924319012639/doc4.xml","form_type":"4"}},{"id":3816512,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-09-14T19:25:54.000Z","date":"2018-09-13","kind":"sale","acquired":false,"shares":3028,"price":6.4993,"value":19679.8804,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were sold to cover the tax obligation that occurred upon the vesting of an RSU."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.25 to $6.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":173720,"source":{"system":"sec-edgar","filing":"0001567619-18-002681","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000156761918002681/doc1.xml","form_type":"4"}},{"id":3816511,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-09-14T19:25:54.000Z","date":"2018-09-12","kind":"grant","acquired":true,"shares":87200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units payable in common stock that vest in four equal annual installments from the grant date of September 12, 2018."}],"balance_after":176748,"source":{"system":"sec-edgar","filing":"0001567619-18-002681","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000156761918002681/doc1.xml","form_type":"4"}},{"id":3824477,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-09-06T19:40:24.000Z","date":"2018-09-04","kind":"sale","acquired":false,"shares":4504,"price":7.1268,"value":32099.1072,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover the tax obligation that occurred upon the vesting of an RSU."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.05 to $7.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":89548,"source":{"system":"sec-edgar","filing":"0001567619-18-002235","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000156761918002235/doc1.xml","form_type":"4"}},{"id":4067120,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-02-12T20:20:47.000Z","date":"2018-02-08","kind":"grant","acquired":true,"shares":174400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the Option vest in 48 equal monthly installments from the vesting commencement date of February 8, 2018."}],"balance_after":174400,"derivative":{"exercise_price":6.05,"expiration_date":"2028-02-07","underlying":"Common Stock","underlying_shares":174400},"source":{"system":"sec-edgar","filing":"0001209191-18-009387","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919118009387/doc4.xml","form_type":"4"}},{"id":4134115,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-12-13T20:19:36.000Z","date":"2017-12-11","kind":"grant","acquired":true,"shares":16312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units payable in common stock that vest in four equal annual installments from the grant date of December 11, 2017."}],"balance_after":94052,"source":{"system":"sec-edgar","filing":"0001209191-17-065523","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919117065523/doc4.xml","form_type":"4"}},{"id":4209808,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-09-14T21:23:04.000Z","date":"2017-09-12","kind":"grant","acquired":true,"shares":32625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units payable in common stock that vest in four equal annual installments from the grant date of September 12, 2017."}],"balance_after":77740,"source":{"system":"sec-edgar","filing":"0001209191-17-052895","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919117052895/doc4.xml","form_type":"4"}},{"id":4217002,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-09-06T16:32:45.000Z","date":"2017-09-01","kind":"sale","acquired":false,"shares":4885,"price":11.7085,"value":57196.0225,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover the tax obligation that occurred upon the vesting of an RSU."}],"balance_after":45115,"source":{"system":"sec-edgar","filing":"0001209191-17-051631","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919117051631/doc4.xml","form_type":"4"}},{"id":4282967,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-06-14T21:15:35.000Z","date":"2017-06-12","kind":"grant","acquired":true,"shares":32625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the Option vest in 48 equal monthly installments from the vesting commencement date of June 12, 2017."}],"balance_after":32625,"derivative":{"exercise_price":10.75,"expiration_date":"2027-06-11","underlying":"Common Stock","underlying_shares":32625},"source":{"system":"sec-edgar","filing":"0001209191-17-040000","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919117040000/doc4.xml","form_type":"4"}},{"id":4603633,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2016-09-14T16:22:23.000Z","date":"2016-09-12","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the Option vest over a four-year period as follows: 25% of the shares vest on the one year anniversary of the vesting commencement date of August 31, 2016 and thereafter the remaining shares vest in a series of equal monthly installments at a rate of one thirty-sixth (1/36th) per month."}],"balance_after":250000,"derivative":{"exercise_price":14.29,"expiration_date":"2026-09-11","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001209191-16-141404","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919116141404/doc4.xml","form_type":"4"}},{"id":4603632,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2016-09-14T16:22:23.000Z","date":"2016-09-12","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units payable in common stock that vest in four equal annual installments from the vesting commencement date of August 31, 2016."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001209191-16-141404","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000120919116141404/doc4.xml","form_type":"4"}}]}